Chargement en cours...
Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia
Although cure rates for pediatric acute lymphoblastic leukemia (ALL) have now risen to more than 90%, subsets of patients with high-risk features continue to experience high rates of treatment failure and relapse. Recent work in minimal residual disease stratification and leukemia genomics have incr...
Enregistré dans:
| Publié dans: | Ther Adv Hematol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7268159/ https://ncbi.nlm.nih.gov/pubmed/32537116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620720927575 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|